McDermott Represents SubjectWell in Its Cross-Border Acquisition of Trials24
October 08, 2024
October 08, 2024
CHICAGO, Illinois, Oct. 8 -- McDermott Will and Emery, a law firm, issued the following news release:
International law firm McDermott Will & Emery represented SubjectWell, a Texas-based provider of the most accurate, diverse, predictable, and patient-centric patient recruitment platform and portfolio company of Windrose Health Investors (WindRose), in its acquisition of Germany-based Trials24, provider of global digital patient recruitment solutions. This strategic partnership . . .
International law firm McDermott Will & Emery represented SubjectWell, a Texas-based provider of the most accurate, diverse, predictable, and patient-centric patient recruitment platform and portfolio company of Windrose Health Investors (WindRose), in its acquisition of Germany-based Trials24, provider of global digital patient recruitment solutions. This strategic partnership . . .